Impact of SARS-CoV-2 Infection on Essential Tremor: A Retrospective Clinical and Kinematic Analysis.

Impact of SARS-CoV-2 Infection on Essential Tremor: A Retrospective Clinical and Kinematic Analysis.

Publication date: Oct 09, 2024

In the past few years, SARS-CoV-2 infection has substantially impacted public health. Alongside respiratory symptoms, some individuals have reported new neurological manifestations or a worsening of pre-existing neurological conditions. We previously documented two cases of essential tremor (ET) who experienced a deterioration in tremor following SARS-CoV-2 infection. However, the effects of SARS-CoV-2 on ET remain largely unexplored. This study aims to evaluate the impact of SARS-CoV-2 infection on a relatively broad sample of ET patients by retrospectively comparing their clinical and kinematic data collected before and after the exposure to SARS-CoV-2. We surveyed to evaluate the impact of SARS-CoV-2 infection on tremor features in ET. Subsequently, we retrospectively analysed clinical and kinematic data, including accelerometric recordings of postural and kinetic tremor. We included 36 ET patients (14 females with a mean age of 71. 1 +/- 10. 6 years). Among the 25 patients who reported SARS-CoV-2 infection, 11 (44%) noted a subjective worsening of tremor. All patients reporting subjective tremor worsening also exhibited symptoms of long COVID, whereas the prevalence of these symptoms was lower (50%) in those without subjective exacerbation. The retrospective analysis of clinical data revealed a tremor deterioration in infected patients, which was not observed in non-infected patients. Finally, kinematic analysis revealed substantial stability of tremor features in both groups. The study highlighted a potential correlation between the SARS-CoV-2 infection and clinical worsening of ET. Long COVID contributes to a greater impact of tremor on the daily life of ET patients.

Open Access PDF

Concepts Keywords
Daily Essential tremor
Females SARS-CoV-2
Kinematic Worsening
Retrospective
Tremor

Semantics

Type Source Name
disease MESH SARS-CoV-2 Infection
pathway REACTOME SARS-CoV-2 Infection
disease MESH Essential Tremor
disease MESH neurological manifestations
disease MESH tremor
disease MESH long COVID
disease MESH Anxiety
disease MESH Depression
disease MESH Posture
disease MESH Severe Acute Respiratory Syndrome
disease MESH infection
drug DRUGBANK Safrazine
disease MESH Parkinson’s Disease
disease MESH Movement Disorders
disease MESH cognitive impairment
drug DRUGBANK Oxygen
disease MESH ‘brain fog
drug DRUGBANK Pyruvic acid
drug DRUGBANK Esomeprazole
disease MESH emotional stress
disease MESH complications
disease MESH syndrome
disease MESH neurological disorders
disease MESH dementia
disease MESH viral infection
pathway REACTOME Reproduction
disease MESH ataxia
disease MESH gait
disease MESH multiple system atrophy
drug DRUGBANK Trestolone
disease MESH Neuroinflammation
disease MESH cerebellar dysfunction
disease MESH Pathogenesis
drug DRUGBANK Valproic Acid
drug DRUGBANK Propranolol
disease MESH neurodegenerative disease

Original Article

(Visited 4 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *